Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Ingested (oral) adrenocorticotropic hormone (ACTH) inhibits interleukin-17 in the central nervous system after adoptive transfer of T helper (Th)1/Th17 T cells in the mouse model of multiple sclerosis, experimental autoimmune encephalomyelitis.
Journal: Journal of the neurological sciences
Published: August 04, 2023
The genealogy, methodology, similarities and differences of immune reconstitution therapies for multiple sclerosis and neuromyelitis optica.
Journal: Autoimmunity reviews
Published: August 01, 2022
Ingested (Oral) Adrenocorticotropic Hormone Inhibits IL-17 in the Central Nervous System in the Mouse Model of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.
Journal: ImmunoHorizons
Published: March 28, 2022
Anti-Inflammatory Agents: An Approach to Prevent Cognitive Decline in Alzheimer's Disease.
Journal: Journal of Alzheimer's disease : JAD
Published: November 29, 2021
A proposal: How to study pro-myelinating proteins in MS.
Journal: Autoimmunity reviews
Published: August 10, 2021
Immune reconstitution therapy in NMOSD.
Journal: Multiple sclerosis and related disorders
Published: January 05, 2021
Review of approved NMO therapies based on mechanism of action, efficacy and long-term effects.
Journal: Multiple sclerosis and related disorders
Published: July 13, 2020
Plegia to walking: AHSCBMT in severe NMOSD relapse.
Journal: BMJ neurology open
Published: July 13, 2020
In MS: Immunosuppression is passé.
Journal: Multiple sclerosis and related disorders
Published: November 21, 2019
Ingested ACTH blocks Th17 production by inhibiting GALT IL-6.
Journal: Journal of the neurological sciences
Published: October 09, 2019
Clinical and MRI efficacy of sc IFN β-1a tiw in patients with relapsing MS appearing to transition to secondary progressive MS: post hoc analyses of PRISMS and SPECTRIMS.
Journal: Journal of neurology
Published: March 29, 2019
Tumefactive demyelination: Clinical outcomes, lesion evolution and treatments.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: February 20, 2019
Last Updated: 09/26/2026